Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avacopan Added to Standard-of-care Therapy in ANCA-associated Vasculitis With Severe Kidney Involvement: a Randomized, Placebo-controlled, Double-blinded Multicenter Superiority Study

NCT07373262 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT07373262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07373262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avacopan Added to Standard-of-care Therapy in ANCA-associated Vasculitis With Severe Kidney Involvement: a Randomized, Placebo-controlled, Double-blinded Multicenter Superiority Study
Lead sponsor
University Hospital, Toulouse
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
July 1, 2030
Enrollment
130 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

anca-associated vasculitis (aav)